Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma

Show simple item record

dc.contributor.author Anuradha, KWDA
dc.contributor.author Prematilake, GLDC
dc.contributor.author Batuwita, BAU
dc.contributor.author Kannangoda, KASR
dc.contributor.author Hewagamage, US
dc.contributor.author Wijeratne, S
dc.contributor.author Lankatilake, Kantha
dc.contributor.author de Silva, KSH
dc.date.accessioned 2023-06-04T10:53:35Z
dc.date.available 2023-06-04T10:53:35Z
dc.date.issued 2019
dc.identifier.citation Kantha, L., & de Silva, K. S. H. (2019). Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma. en_US
dc.identifier.uri http://archive.cmb.ac.lk:8080/xmlui/handle/70130/7112
dc.description.abstract Background: Inhaled corticosteroids (ICS) are the most effective treatment for children with persistent asthma. However adverse effects of ICS on Hypothalamo Pituitary Adrenal (HPA) axis, growth and bone metabolism are a concern. Hence the primary objective of this study was to describe the effects of long term inhaled corticosteroid therapy (ICS) on adrenal function, growth and bone health in children with asthma in comparison to an age and sex matched group of children with asthma who were not on long term ICS. Describing the association between the dose of ICS and duration of therapy on the above parameters were secondary objectives. Method: Seventy children with asthma on ICS and 70 controls were studied. Diagnosis of asthma in selected patients was reviewed according to the criteria laid down by GINA 2018 guidelines. The estimated adult heights were interpreted relative to their Mid Parental Height (MPH) range. Serum calcium, alkaline phosphatase and vitamin D levels were analyzed in both groups and cortisol value at 30 min following a low dose short synacthen test was obtained from the study group. The average daily dose of ICS (Beclamethasone) was categorized as low, medium and high (100–200, 200–400, > 400 μg /day) respectively according to published literature. Results: Heights of all children were within the MPH range. There was no statistically significant difference in the bone profiles and vitamin D levels between the two groups (Ca: p = 0.554, vitamin D: p = 0.187) but vitamin D levels were insufficient (< 50 nmol/l) in 34% of cases and 41% of controls. Suppressed cortisol levels were seen in 24%. Doses of ICS were low, medium and high in 56, 32 and 12% of children respectively. The association between adrenal suppression with longer duration of therapy (p < 0.01) and with increasing dose of ICS (p < 0.001) were statistically significant. Conclusion: ICS had no impact on the growth and bone profiles but its dose and duration were significantly associated with adrenal suppression. Keywords: Asthma, Inhaled corticosteroids, Growth, Adrenal suppression, Bone metabolism, Vitamin D en_US
dc.language.iso en en_US
dc.publisher BMC en_US
dc.subject Asthma en_US
dc.subject Inhaled corticosteroids en_US
dc.subject Growth en_US
dc.subject Adrenal suppression en_US
dc.subject Bone metabolism en_US
dc.subject Vitamin D en_US
dc.title Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account